bioSyntagma has been awarded “Best Oncology-Focused Precision Medicine Company 2018” by Global Health and Pharma, a UK-based publication that recognizes global companies for improving public health, enhancing patient care, and lowering healthcare costs. This award follows several commercial milestones with strategic partners and Big Pharma using bioSyntagma’s beta-instruments to offer biomarker discovery services.Continue reading
Category Archives: AZBio News
Getting Ready for Tax Time – IRS Tips
The IRS information in this post is provided as a service to AZBio Members and their families. Please feel free to share it with your teams.Continue reading
RiboMed receives NICHD award to develop diagnostic test for endometriosis
RiboMed Biotechnologies, Inc., a CLIA-certified diagnostic company, today announced the receipt of a $165,000 Small Business Innovative Research contract awarded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The project, entitled “Non-invasive assay for the diagnosis and treatment of endometriosis” will focus on the development of a test for early detection of endometriosis from a woman’s bodily fluids using an epigenetic biomarker panel, including gene-specific DNA methylation.Continue reading
ASU startup wins Arizona Innovation Challenge
Breezing, a spinout company that was the result of discoveries made at Arizona State University’s Biodesign Institute, was recently named an Arizona Innovation Challenge winner by the Arizona Commerce Authority.Continue reading
9,000 Attend STEM Outreach Event
University of Arizona, Cox Communications Team Up for Fifth Annual Family-Friendly Event to Inspire All AgesContinue reading
Opportunity Alert: Flinn Scholars Program Info Sessions
The Flinn Scholars Program will host five information sessions this spring across Arizona to share the benefits of one of the nation’s most prestigious merit-based scholarships and present strategies to assist in building the strongest application.Continue reading
‘Why Women?’ — Studying the Role of Gender in Alzheimer’s Disease
Roberta Diaz Brinton, PhD, inaugural director of the Center for Innovation in Brain Science at the University of Arizona Health Sciences, received $5.9 million from the National Institute on Aging to study the role of gender in Alzheimer’s disease and develop precision medicine interventions to prevent — and potentially reverse — the course of the disease in both women and men.Continue reading
Invest Southwest Reveals 2019 Venture Madness Finalists
Thirty four companies given the opportunity to present for a chance to earn cash prizes, access to investors, recognition and the coveted title of Venture Madness Champion